The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems
Open accessAbstract
Multiligand receptorsScavenger receptors (SRs) are defined as cell surface membrane proteins that bind chemically modified lipoproteins, such as acetylated LDL (AcLDL) and oxidized LDL (OxLDL), and often many other types of ligands (1-3).Initially, scavenger receptor activity was identified as "AcLDL receptor activity" by Brown, Goldstein, and colleagues (2), who were developing an in vitro model for the deposition of LDL cholesterol in macrophages in artery walls during the initial stages of atherosclerotic plaque formation.They discovered that acetylation of LDL redirected the uptake of the particles from classic LDL receptors to a novel AcLDL receptor activity, which appeared to be relatively macrophage-specific.The massive, receptor-mediated uptake of cholesterol from modified LDL can convert cultured macrophages into cholesteryl ester-filled foam cells, similar to those in atherosclerotic plaques.As a consequence, investigators interested in lipoprotein metabolism and atherosclerosis have focused considerable attention on these receptors.Brown and Goldstein also showed that these macrophage receptors mediate the binding of a remarkably wide variety of polyanionic ligands (e.g., modified proteins, sulfated polysaccharides, and certain polynucleotides; reviewed in refs.2-4).Such broad binding specificity prompted the name change to "scavenger receptor" and the proposal (1, 3) that these receptors participate in the innate immune system by serving as pattern recognition receptors (5) that bind a wide variety of components of pathogens (1).Such recognition is a prerequisite to mounting cellular and/or humoral responses to protect the body.Current data suggest that SRs can participate in innate immunity (1,4,6).With respect to their broad ligand specificities and their likely role in protecting the host, SRs are similar to hepatic cytochrome P450s.The broad and overlapping substrate specificities that characterize that large family of enzymes allow the liver to inactivate a wide variety of potentially toxic small molecules.By analogy, it seemed likely that there would be multiple classes of scavenger receptors with overlapping specificities to permit the recognition of many different potentially pathogenic structures (1) and that SRs would have arisen early in evolution to allow multicellular organisms to recognize a multitude of endogenous or exogenous structures (1).Indeed, over the past decade, the cDNAs for at least nine distinct scavenger receptors have been cloned and analyzed from organisms as diverse as mammals and fruit flies.These receptors have been categorized into broad classes (A, B, C, etc.) based on global structural similarities.In many cases, the members of a given class have been subdivided into "types" based on more subtle structural differences, including multiple proteins from a single gene generated by alternative RNA splicing (1).The class A, type I and II scavenger receptors (SR-AI/II), the first SRs to be identified and cloned (3), are the subject of the article by Platt and Gordon in this Perspective series (4).Here, I will consider the class B, type I scavenger receptor, SR-BI, and studies that have refocused interest in scavenger receptors on lipoprotein metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Approaching the Asymptote? Evolution and Revolution in Immunology
Janeway, C. A. (1989) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1989.054.01.003 · Cited by 3,252
LIPOPROTEIN METABOLISM IN THE MACROPHAGE: Implications for Cholesterol Deposition in Atherosclerosis
Brown, M. S., & Goldstein, J. L. (1983) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.52.070183.001255 · Cited by 2,300
Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor
Acton, S., Rigotti, A., Landschulz, K. T., Xu, S., Hobbs, H. H., & Krieger, M. (1996) · Science · doi:10.1126/science.271.5248.518 · Cited by 2,026
Self-citationReceptor-Mediated Endocytosis: Concepts Emerging from the LDL Receptor System
Goldstein, J. L., Brown, M. S., Anderson, R. G. W., Russell, D. W., & Schneider, W. J. (1985) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.01.110185.000245 · Cited by 1,600
CD36 is a receptor for oxidized low density lipoprotein
Endemann, G., Stanton, L. W., Madden, K. S., Bryant, C. M., White, R. T., & Protter, A. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50272-1 · Cited by 1,281
Febbraio, M., Hajjar, D. P., & Silverstein, R. L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14006 · Cited by 1,193
Krieger, M., & Krieger, J. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.003125 · Cited by 1,160
Self-citationJeffery, C. J. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01335-8 · Cited by 1,016
LRP: a multifunctional scavenger and signaling receptor
Herz, J., & Strickland, D. K. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13992 · Cited by 908
Rigotti, A., Trigatti, B. L., Penman, M., Rayburn, H., Herz, J., & Krieger, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12610 · Cited by 860
Self-citation
Cited by
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
Khovidhunkit, W., Kim, M.-S., Memon, R. A., Shigenaga, J. K., Moser, A. H., Feingold, K. R., & Grunfeld, C. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r300019-jlr200 · Cited by 1,481
MiR-33 Contributes to the Regulation of Cholesterol Homeostasis
Rayner, K. J., Suárez, Y., Dávalos, A., Parathath, S., Fitzgerald, M. L., Tamehiro, N., Fisher, E. A., Moore, K. J., & Fernández-Hernando, C. (2010) · Science · doi:10.1126/science.1189862 · Cited by 1,260
Febbraio, M., Hajjar, D. P., & Silverstein, R. L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14006 · Cited by 1,193
Wang, N., Lan, D., Chen, W., Matsuura, F., & Tall, A. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403506101 · Cited by 1,061
Metadata
- Authors
- Krieger, M.
- Venue
- Journal of Clinical Investigation
- Published
- 2001-09-15
- Volume
- 108
- Issue
- 6
- Pages
- 793-797
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2164724187
- Cited by
- 406
- References
- 32
- FWCI
- 25.46
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems. https://app.cochat.ai/papers/10.1172/jci14011
- The paper
- Krieger, M. (2001). Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems. Journal of Clinical Investigation. https://doi.org/10.1172/jci14011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.